Pro Medicus Limited announces an Equity Buyback for 10,421,157 shares, representing 10% of its issued share capital.
April 31, 2021 at 06:37 pm EDT
Share
Pro Medicus Limited (ASX:PME) announces a share repurchase program. Under the program, the company will repurchase up to 10,421,157 shares, representing 10% of its issued share capital. The purpose of the program is capital management. The program will expire on March 31, 2022. As of April 1, 2021, the company has 104,211,574 shares in issue.
Pro Medicus Limited is an Australia-based healthcare informatics company. The Company provides a full range of medical imaging software and services to hospitals, imaging centers and health care groups in Australia, North America and Europe. Its products include Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro and Visage Ease. Its Visage RIS is a radiology information systems (RIS) medical software for practicing of management, training, installation and professional services. Visage RIS capabilities include patient registration, billing, scheduling, typing, HL7 integration, financial reporting, digital dictation and voice recognition integration. Its Visage 7.0 is a healthcare imaging software that provides clinicians with visualization capability for rapidly viewing 2-D, 3-D and 4-D medical images and picture archive and communication system (PACS)/digital imaging software that is sold directly and to original equipment manufacturers (OEM), training, installation and others.
PRO MEDICUS LIMITED 
